µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© XaMsIyhI
6wZ)GLW[
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© `X<a(5[vV3
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© \=o0MR
1.Co-stimulators (or co-stimulating molecules) =uR3|U(.|u
2.NK-kB j@{dsS:6
3.Immunoglobulin superfamily CW]
Th-xc
4.antigen-presenting cell (APC) B|'}HBk
P
5.death domain `Io
#440;
6.CCR and CXCR @7{.err!
7.Lectin (or mitogen) aS~~*UHW
8.Clusters of differentiation, CD) M;YJpi
9.B7 family ?F*I2rt#
10.Cytotoxic T lymphocyte, CTL) + f:!9)C
11.IL-15 and IL-15 receptor (IL-15R) n+nZ;GJ5d
12.MHC restriction %.HLO.A
13.Affinity-chromatography PX` xr1o
14.Cyctosprin A, CsA L$y~\1-
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) `g0^W/j
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Z$zX%w
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 Jm"W+! E
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ?TI]0)
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢á¹¹¼°Æäʶ±?¿¹ÔµÄÌØµã¡£ $9:
@M.
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© z#GSt
ZT
ÃâÒßѧרҵ£º e>bARK<
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ =YD<q:n4
Ïû»¯ÄÚ¿Æ£º =&(e* u_
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 1aUg({
ѪҺ²¡Ñ§×¨Òµ£º Z'Pe%}3
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿